Pfizer on Monday struck a roughly $43 billion deal for Seagen to bulk up its cancer treatment portfolio.
You are here: Home / Pfizer looks beyond Covid sales with $43 billion deal for cancer drugmaker Seagen
Market News and Views
Pfizer on Monday struck a roughly $43 billion deal for Seagen to bulk up its cancer treatment portfolio.